| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1047-9651(18)30204-3 |
| P698 | PubMed publication ID | 10370939 |
| P2093 | author name string | Schapiro RT | |
| P2860 | cites work | Management of bladder dysfunction in multiple sclerosis | Q70650100 |
| The current management of multiple sclerosis | Q70974929 | ||
| Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group | Q71656658 | ||
| Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis | Q72857069 | ||
| Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) | Q74575024 | ||
| Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis | Q74575031 | ||
| Spastic paraplegia of middle age; a clinicopathological study | Q78589876 | ||
| Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 | ||
| Glutethimide treatment of disabling action tremor in patients with multiple sclerosis and traumatic brain injury | Q28275387 | ||
| Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group | Q28293763 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group | Q34344201 | ||
| Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) | Q34375520 | ||
| Tumor necrosis factor identified in multiple sclerosis brain | Q36356662 | ||
| The interferons. Mechanisms of action and clinical applications | Q36677129 | ||
| Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor | Q41920173 | ||
| Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis | Q42010225 | ||
| Overview of azathioprine treatment in multiple sclerosis | Q42033600 | ||
| Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells | Q42941989 | ||
| A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group | Q43800957 | ||
| Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations | Q44022365 | ||
| Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. | Q45937899 | ||
| Megadose corticosteroids in multiple sclerosis | Q48196502 | ||
| Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis | Q51252927 | ||
| Drug therapy: spasticity (first of two parts). | Q51870962 | ||
| Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis | Q61657788 | ||
| A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group | Q68081121 | ||
| Fatigue in Multiple Sclerosis | Q68307338 | ||
| High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations | Q68859583 | ||
| Intrathecal baclofen for severe spinal spasticity | Q69504207 | ||
| Drug treatment of multiple sclerosis | Q69839726 | ||
| Amantadine therapy for fatigue in multiple sclerosis | Q69912682 | ||
| A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis | Q70131429 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 437-46, ix | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Physical medicine and rehabilitation clinics of North America | Q26842218 |
| P1476 | title | Medications used in the treatment of multiple sclerosis | |
| P478 | volume | 10 |
Search more.